CVS pulls heartburn drug Zantac from shelves over cancer concerns

WOONSOCKET, R.I. — CVS officials announced the suspension of the sale of Zantac, along with any CVS products containing ranitidine — a drug used to treat ulcers and heartburn.

The announcement followed an alert from the FDA, which said ranitidine might contain a possible human carcinogen and cause cancer.

Zantac and ranitidine products have not been recalled, and the FDA isn’t recommending people stop taking these products.

Nonetheless, CVS officials said customers can return the products for a refund.

CVS officials said stores would continue to sell other over-the-counter heartburn drugs, including Pepcid and Tagamet.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.